Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_assertion type Assertion NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_head.
- NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_assertion description "[We also observed enhanced expression of IRF3 (64 � 6.36 versus 36.1 � 5.57, P = 0.004) and IRF5 (40 � 5.25 versus 22.5 � 2.6%, P = 0.010) restricted to this circulating pDC subset from SLE patients versus healthy controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_provenance.
- NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_assertion evidence source_evidence_literature NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_provenance.
- NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_assertion SIO_000772 25130328 NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_provenance.
- NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_assertion wasDerivedFrom befree-20150227 NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_provenance.
- NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_assertion wasGeneratedBy ECO_0000203 NP515062.RABg2a15sIJE_Dli5bod2pkjVX26kWsFJ75tz7F84CrOs130_provenance.